Cargando…

Targeting iron metabolism in osteosarcoma

Osteosarcoma (OS) is the most common primary solid malignant tumour of bone, with rapid progression and a very poor prognosis. Iron is an essential nutrient that makes it an important player in cellular activities due to its inherent ability to exchange electrons, and its metabolic abnormalities are...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaowei, Zhao, Jiazheng, Feng, Helin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006389/
https://www.ncbi.nlm.nih.gov/pubmed/36897430
http://dx.doi.org/10.1007/s12672-023-00637-y
_version_ 1784905286978371584
author Ma, Xiaowei
Zhao, Jiazheng
Feng, Helin
author_facet Ma, Xiaowei
Zhao, Jiazheng
Feng, Helin
author_sort Ma, Xiaowei
collection PubMed
description Osteosarcoma (OS) is the most common primary solid malignant tumour of bone, with rapid progression and a very poor prognosis. Iron is an essential nutrient that makes it an important player in cellular activities due to its inherent ability to exchange electrons, and its metabolic abnormalities are associated with a variety of diseases. The body tightly regulates iron content at the systemic and cellular levels through various mechanisms to prevent iron deficiency and overload from damaging the body. OS cells regulate various mechanisms to increase the intracellular iron concentration to accelerate proliferation, and some studies have revealed the hidden link between iron metabolism and the occurrence and development of OS. This article briefly describes the process of normal iron metabolism, and focuses on the research progress of abnormal iron metabolism in OS from the systemic and cellular levels.
format Online
Article
Text
id pubmed-10006389
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100063892023-03-12 Targeting iron metabolism in osteosarcoma Ma, Xiaowei Zhao, Jiazheng Feng, Helin Discov Oncol Review Osteosarcoma (OS) is the most common primary solid malignant tumour of bone, with rapid progression and a very poor prognosis. Iron is an essential nutrient that makes it an important player in cellular activities due to its inherent ability to exchange electrons, and its metabolic abnormalities are associated with a variety of diseases. The body tightly regulates iron content at the systemic and cellular levels through various mechanisms to prevent iron deficiency and overload from damaging the body. OS cells regulate various mechanisms to increase the intracellular iron concentration to accelerate proliferation, and some studies have revealed the hidden link between iron metabolism and the occurrence and development of OS. This article briefly describes the process of normal iron metabolism, and focuses on the research progress of abnormal iron metabolism in OS from the systemic and cellular levels. Springer US 2023-03-10 /pmc/articles/PMC10006389/ /pubmed/36897430 http://dx.doi.org/10.1007/s12672-023-00637-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Ma, Xiaowei
Zhao, Jiazheng
Feng, Helin
Targeting iron metabolism in osteosarcoma
title Targeting iron metabolism in osteosarcoma
title_full Targeting iron metabolism in osteosarcoma
title_fullStr Targeting iron metabolism in osteosarcoma
title_full_unstemmed Targeting iron metabolism in osteosarcoma
title_short Targeting iron metabolism in osteosarcoma
title_sort targeting iron metabolism in osteosarcoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006389/
https://www.ncbi.nlm.nih.gov/pubmed/36897430
http://dx.doi.org/10.1007/s12672-023-00637-y
work_keys_str_mv AT maxiaowei targetingironmetabolisminosteosarcoma
AT zhaojiazheng targetingironmetabolisminosteosarcoma
AT fenghelin targetingironmetabolisminosteosarcoma